Archived Monthly Oncology Tumor Boards: Uveal Melanoma: Treatment of Metastatic Disease
The management of metastatic uveal melanoma still presents a major clinical challenge, and it is important for healthcare providers to be aware of the most current recommendations by the NCCN Panel.
Category
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
Archived Monthly Oncology Tumor Boards: Management of Relapsed/Refractory Mantle Cell Lymphoma
Clinicians are challenged to remain up-to-date about the treatment advances that will enable them to make informed decisions to optimize the clinical outcome of patients with relapsed/refractory disease.
Category
- Non-Hodgkin's Lymphoma
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Breast Cancer
The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of breast cancer in Black patients.
Category
- Breast Cancer
Format
- Enduring Activity
Credits
- 0.50 AAPA Category 1 CME credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC contact hours
- 0.50 Participation
Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Prostate Cancer
The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of prostate cancer in Black patients.
Category
- Prostate Cancer
Format
- Enduring Activity
Credits
- 0.50 AAPA Category 1 CME credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC contact hours
- 0.50 Participation
Providing Access to Cancer Care in Historically Marginalized Communities: Lessons Learned from Dana-Farber’s Cancer Care Equity Program
Disparities in cancer care in historically marginalized communities have been well documented. Identification of patients at risk for health inequity and strategies to mitigate disparities can help address current practice gaps in historically marginalized communities.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Operational Excellence for Inpatient Rounding
As quality measures are set by governing bodies to reflect reimbursement, institutions not only have to be fiscally responsible but at the same time responsible for improving quality of care. Multidisciplinary engagement and buy-in are essential in this quest.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Early Involvement of Palliative Care in Cancer Treatment
The early involvement of palliative care can help address and treat these other aspects of cancer, improving the patient’s quality of life and, in some cases, outcomes. Too often, palliative care is instituted late in the disease trajectory, if at all, which can lead to unnecessary suffering on the part of patients and caregivers.
Category
- Palliative Care
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
New Challenges in the Management of Pulmonary Toxicities
Pulmonary function is important to maintaining homeostasis and dysfunction can result in life-threatening complications. There is a need to discuss the incidence, prevention, and management of pulmonary toxicities given that numerous cancer treatments have the potential to cause pulmonary dysfunction. Clinician education on this topic can help them provide optimal care for patients experiencing pulmonary toxicity.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Management of Acute Hyperglycemia
Hyperglycemia is a common complication of cancer and its treatments. Appropriate monitoring and management of hyperglycemia is critical to prevent glycemic emergencies and optimize response to chemotherapy.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Updates in Biomarker Testing in Non-Small Cell Lung Cancer
Biomarker testing is becoming more important due to the shift in cancer care to targeted therapies. Especially in NSCLC, there are many new updates in which biomarkers should be tested, when testing is required or recommended, and what the barriers are to implementing testing for all patients.
Category
- Lung Cancers
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation